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Abstract
Background: the primary objective was to  develop an adjective checklist, the Fatigue Quality List 
(FQL), aimed at assessing different perceptions o f fatigue.
Methods: 961 participants filled out the FQL (28 adjectives). A  component and confirm atory 
factor analyses were performed and psychometric properties were evaluated. Differences on 
factor scores between different patients' groups were investigated and pre- and post treatment 
scores were compared in demonstrating change o f perceptions after treatment o f fatigue.
Results: Four independent factors were found w ith adequate psychometric properties. Different 
perceptions were found between the patients' groups. Patients who were recovered after 
treatm ent fo r fatigue showed similar scores on the factors as healthy controls.
Conclusion: The FQL appears to  be a promising too l in measuring different perceptions o f fatigue, 
which can be especially interesting fo r clinical practice.
Background
What is m eant by fatigue? Most people are familiar with 
the experience of fatigue, but the meaning of this sensa­
tion can differ between people and even within one per­
son the meaning of fatigue can change. Therefore, fatigue 
can be defined in different ways and there is no 'gold 
standard'. Healthy people would characterise fatigue as a 
pleasant, acute, normal and regulating phenom enon after 
exercise or a busy day, disappearing after a good night's 
sleep or a period of rest. However, fatigue can also have a 
more negative connotation as in fatigue experienced by
patients with a health problem. To them fatigue can be a 
chronic, disabling and life- and activity-limiting experi­
ence [1-6].
There are also differences in the factors underlying fatigue 
severity between patients with different somatic condi­
tions. Processes involved in the experience of fatigue in 
patients with chronic fatigue syndrome (CFS) are clearly 
different from processes related to the experience of 
fatigue in patients with multiple sclerosis (MS) [2] and
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there are many differences between severely fatigued 
breast cancer survivors and females with CFS [7].
Because fatigue is no t clearly defined, poor communica­
tion regarding fatigue exist in the clinical practice [8]. 
Additionally, health care professionals find consultations 
on fatigue difficult and are often dissatisfied with or 
uncertain about the care they provide to patients with 
fatigue complaints [9,10]. W ithout appropriate assess­
ment, recognition and providing the proper management 
to patients with chronic fatigue is difficult. The first neces­
sary step towards improving recognition and manage­
m ent is a thorough understanding of the symptom.
Until now fatigue scales are mostly used to measure 
fatigue severity [11]. However, fatigue severity does not 
reflect a persons' perception and appraisal of the fatigue. 
Therefore, the quantitative way of assessing fatigue fails to 
capture the nuances and differences in  the experience of 
fatigue. In pain research assessment methods already 
exists in determining the quality of pain in a patient by 
using adjectives [12,13].
In this study an adjective checklist, the Fatigue Quality List 
(FQL), was constructed aimed at assessing different per­
ceptions of fatigue. The development of the FQL was 
described and additionally three research questions were 
investigated:
1. Is the FQL a reliable and valid instrument to assess dif­
ferent perceptions of fatigue?
2. Are perceptions of fatigue different between several 
patient groups with and without chronic fatigue com­
plaints and healthy controls?
3. Do perceptions of fatigue change in patients who 
recover after treatment for fatigue?
Methods
Materials
Fatigue Quality List
Researchers and clinicians working at the Expert Centre 
Chronic Fatigue of the Radboud University Nijmegen 
Medical Centre made a large list of all possible adjectives 
that can be used to characterize the feeling of fatigue. The 
FQL was developed by asking researchers and health care 
professionals working with patients with unexplained 
fatigue complaints to indicate on this large list which of 
the adjectives best fitted with the experience of the fatigue 
described by their patients. The final list consisted of 28 
adjectives most frequently mentioned by the raters.
In filling out the FQL, subjects are instructed to mark with 
a cross which of the 28 adjectives fit their experienced
fatigue. Multiple answers are possible. In this study the 
Dutch version of the FQL was used. However, the adjec­
tives were translated into English by a back-translation 
procedure.
Fatigue severity was measured by a subscale of the Check­
list Individual Strength (CIS-fatigue) consisting of 8 items 
[14]. Each item was scored on a 7-point Likert scale. High 
scores indicated a high level of fatigue severity. Based on 
research with Chronic Fatigue Syndrome patients, a score 
of 35 or higher on the subscale fatigue severity indicated 
severe feelings of fatigue. Furthermore, the CIS has excel­
lent psychometric properties [1,11].
Patients
Nine-hundred-sixty-one participants with a mean age of 
43.6 years (sd = 10.2, range 18-79) predominantly female 
(65%) filled out the FQL. All were either patients or 
healthy controls participating in scientific studies con­
ducted by the Expert Centre Chronic Fatigue. The total 
group consisted of:
- 219 cancer survivors. Hundred-twenty-eight (mean age
44.8 (sd = 8.9); female 72%) experienced severe chronic 
fatigue and 91 (mean age 46.5 (sd = 6.3); female 100%) 
were not fatigued [3]. Forty-one of these cancer survivors 
were participating in a randomised control trial about the 
effectiveness of cognitive behaviour therapy (CBT) espe­
cially designed to reduce chronic fatigue in cancer survi­
vors [15]. These patients filled out the FQL at pre- and 
post treatment.
- 160 patients who were diagnosed with Chronic Fatigue 
Syndrome (CFS), according to the CDC criteria (mean age 
38.0 (sd = 10.7); female 69%) [4,16]. Eighty-two CFS 
patients who were included in this study were treated for 
their chronic fatigue complaints with CBT [4]. These 
patients filled out the FQL two times, at pre- and post 
treatment.
- 151 employees on sick leave with unexplained fatigue 
complaints (mean age 44.0 (sd = 8.4); female 55%) [17]. 
66 (44%) of these met research criteria for CFS (mean age
42.9 (sd = 8.6); female 61%).
- 276 patients with various neuromuscular disorders. 
Hundred-sixty-five experienced severe fatigue (mean age 
42.2 (sd = 10.6); female 48%) and 120 experienced no 
fatigue complaints (mean age 42.2 (sd = 11.3); female 
48%) [5,18]
- 77 patients who were diagnosed with pancreatitis. Fifty- 
three experienced severe fatigue (mean age 49.3 (10.0); 
female 47%) and 24 were not fatigued (mean age 50.2 (sd 
= 15.5); female 58%).
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- 78 healthy persons who experienced no fatigue com­
plaints (mean age 48.2 (6.2); female 100%) [3].
Statistical analysis
Data analysis was performed using SPSS (version 12.0.1). 
The total participant group was randomly divided into 
two groups. A principal com ponent factor analysis was 
performed in the first group to identify independent fac­
tors. A varimax rotation was used to facilitate the interpre­
tation. Furthermore, factor loadings had to be above .40 
with a .10 or greater difference in loadings with the other 
factors. The scree test and the eigenvalues (above 1) were 
used to identify the num ber of factors. The factor model 
was then tested in the second group by using confirmatory 
factor analyses/AMOS 5.0 (Comparative Fit Index, Good­
ness of Fit Index, Adjusted Goodness of Fit Index [19,20]).
The internal consistency reliability for each factor was cal­
culated using Cronbach's alpha. Spearman's rho correla­
tions were used to evaluate psychometric properties of the 
FQL. To investigate the differences between the groups of 
patients Kruskal-Wallis tests were performed. When the 
Kruskal-Wallis test was significant, Mann-Whitney-U tests 
between the groups followed. The sensitivity to change of 
the FQL was demonstrated by comparing cancer survivors 
and CFS patients at pre- and post treatment assessment, 
using the Wilcoxon Signed Ranks Test of matched pairs. 
To correct for the multiple comparisons, p-value was set 
on < 0.01.
Results 
Factor solution
Three of the 28 adjectives were marked with a cross for less 
than 10% and therefore excluded from further analyses. 
Final analyses were done with the remaining 25 adjec­
tives. Table 1 presents the final factor solution in the first 
group (n = 476). Seven adjectives were excluded of factor 
analysis because factor loadings were < .40 and/or <.10 
difference in loadings with the other factors. Both the 
scree test and eigenvalues indicated a 4-factor solution 
(Table 2). Factor 1 consisted of 5 adjectives, factor 2 of 4 
adjectives, factor 3 of 5 adjectives and factor 4 of 4 adjec­
tives, explaining respectively, 24%, 9%, 6%, 5% of the var­
iance prior to rotation. After rotation the four factors 
explained respectively, 13%, 12%, 10% and 9% of the var­
iance. Factor 1 was labelled as 'Frustrating', Factor 2 as 
'Exhausting', Factor 3 as 'Pleasant' and Factor 4 as 'Fright­
ening'. This four factor model was then tested in the sec­
ond group (n = 485) by using confirmatory factor 
analysis. The fit indices indicated an adequate fit. Chi- 
square (129, n  = 485) = 364.5, p < 0.001; Comparative Fit 
Index = .87; Goodness of Fit Index = .92; Adjusted Good­
ness of Fit Index = .90.
The four factors were recoded on a 0 to 100 scale, facilitat­
ing comparisons between the factors. Higher scores indi-
T a b le  1 : F ina l fa c to r  s o lu t io n : p r in c ip a l-c o m p o n e n ts  analysis w ith  
v a r im a x - ro ta t io n  in th e  f i r s t  g ro u p . C ro n b a ch 's  A lp h a  o f  th e  fo u r  
fa c to rs
F ru s tra t in g E xh a u s tin g P leasan t F r ig h te n in
discouraging .735
incessant .585
annoying .680
persistent .559
frustrating .704
exhausting .690
wearisome .537
extreme .724
unbearable .509
tem porary .400
relaxing .661
fulfilling .713
normal .522
pleasant .792
upsetting .727
frightening .618
inexplicable .490
insuperable .444
C ro n b a ch 's .79 .68 .61 .57
A lp h a
Three adjectives w ere excluded o f factor analysis because they w ere 
marked w ith  a cross fo r less than 10%: Protective, Soothing, 
Threatening. Seven adjectives w ere excluded o f factor analysis 
because factor loadings <.40 and/or <.10 difference in loadings w ith  
the o th e r factors: Demanding, Paralysing, Aggravating, Compelling, 
Treacherous, Insoluble, Acceptable
T a b le  2: p r in c ip a l-c o m p o n e n ts  analysis w ith  v a r im a x -ro ta t io n , 
in it ia l e igenva lues
c o m p o n e n t E igenva lues
1 4.788
2 1.906
3 1.285
4 1.176
5 0.984
6 0.875
7 0.8I3
8 0.742
9 0 .7 I4
10 0.664
II 0.623
12 0.593
I3 0.568
I4 0 .5 I4
I5 0.503
I6 0.445
I7 0.428
I8 0.380
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cate a higher appraisal of the fatigue experience as 
frustrating, exhausting, pleasant and frightening. The final 
version of the FQL and the criteria for scoring are pre­
sented in appendix A.
Is the FQ L a reliable and valid instrument to assess 
different perceptions o f fatigue?
For each factor the internal consistency reliability was calcu­
lated in the entire sample of 961 participants, which dem­
onstrated moderate to adequate internal consistencies for 
all four factors, ranging from .57 to .79 (Table 1).
Supporting convergent validity we found that all four fac­
tors were statistically significant related to fatigue severity 
(CIS-fatigue) (Table 3).
In calculating general psychometric properties statistically 
significant intercorrelations between the four factors were 
found (Table 3). Additionally, low correlations were 
found between the four factors and age and gender, 
explaining less than 3% of the variance.
Are the perceptions o f fatigue different between several 
patient groups with and without chronic fatigue 
complaints and healthy controls?
The non-fatigued groups scored significantly lower on 
Frustrating, Exhausting and Frightening and significantly 
higher on Pleasant compared with the fatigued groups 
(Table 4). The following analyses were performed sepa­
rately in the fatigued groups and the non-fatigued groups.
Frustrating
The non-fatigued groups were similar with respect to the 
mean scores on Frustrating (p = 0.757). Patients with
T a b le  3: C o n v e rg e n t v a lid ity  o f  th e  4 fa c to rs . S p e a rm a n 's  rh o  
c o r re la t io n  in to ta l g ro u p  (N  = 961)
F a c to r F ru s tra tin g E xhausting P leasant F r ig h te n in g
Fatigue .66* .58* -.54* .43*
Severity
Exhausting .54*
Pleasant -.48* -.35*
Frightening .49* .42* -.25*
Age -.16* -.14* .05 -.03
Gender -.09* .03 .11* -.10*
(1 = M, 2 = F)
*  p < 0.01
chronic fatigue syndrome and employees with unex­
plained fatigue scored significantly higher on Frustrating 
with respect to the other fatigued groups.
Exhausting
The non-fatigued patients with various neuromuscular 
disorders scored significantly lower on Exhausting than 
the non-fatigued cancer survivors and the non-fatigued 
patients with pancreatitis. Between the fatigued groups, 
CFS patients scored significantly higher on Exhausting 
than the other groups. Furthermore, fatigued patients 
with pancreatitis scored significantly lower with respect to 
fatigued cancer survivors and employees with unex­
plained fatigue. Additionally, patients with neuromuscu­
lar disorders scored significantly lower than employees 
with unexplained fatigue.
Pleasant
In the non-fatigued group patients with various neu­
romuscular disorders scored significantly lower on Pleas­
T a b le  4: M ean sco re  on 4 fa c to rs : co m p a riso n s  b e tw e e n  fa t ig u e d  d isease-free  c a n ce r p a tie n ts , C FS p a tie n ts , em p lo ye e s  w ith  
u n e xp la in e d  fa t ig u e , fa t ig u e d  p a tie n ts  w ith  n e u ro m u s c u la r disease, fa t ig u e d  p a tie n ts  w ith  p a n c re a tit is , n o n -fa tig u e d  d isease-free  
ca n ce r p a tie n ts , n o n -fa tig u e d  p a tie n ts  w ith  n e u ro m u s c u la r disease, n o n -fa tig u e d  p a tie n ts  w ith  p a n c re a tit is  and  h e a lth y  pe rsons
F ru s tra t in g  E x h a u s tin g  P le a sa n t F r ig h te n in g
A. Fatigued disease-free cancer patients 48.6 (30.9)bc 29.3 (28.6)b,d l l  .7 ( l  7.7)bc 22.7 (24.2)d,e
B. Chronic fatigue syndrome 58.5 (32.2)a,d,e 37.8 (31.5)a,c,d,e 6.6 ( l 3.0)a,cd 25.2 (25.9)d,e
C. Employees w ith  unexplained fatigue 63.7 (29.2)a’d’e 29.5 (2 8 .l)bd 4.3 ( ll.2)a.b.d,e 26.0 (26.6)d,e
D. Fatigued patients w ith  neuromuscular disease 41.8 (32.6)bc 17.8 (24.8)abc l3.6 ( l8 .5 )bc l3.8 (2 0 .l)abc
E. Fatigued patients w ith  pancreatitis 41.1 (3 3 .l)b,c 25.9 (29.8)b 9. l (l3.9)c l4.2 (22.7)abc
F. Non-fatigued disease-free cancer patients 8.1 (16.3) 6.6 (l4.4)g 38.9 (28.3)g 7.7 ( l 7.0)
G. Non fatigued patients w ith  neuromuscular disease 9.0 ( 16.2) 1.7 (7 . l) f,h 24.7 (2 l.3 ) fI 5.6 ( l 3.9)
H. Non-fatigued patients w ith  pancreatitis 13.3 (28.1) 9.4 (l7.8)g 29.2(23.6) 5.2 ( l 2.7)
I. Healthy persons 7.7 (18.3) 3.9 ( l 3.4) 36.2 (23.3)g 3.2 ( l 0.2)
a. significantly d iffe rent from  group A, M ann-W hitney tes t p < 0.01
b. significantly d iffe rent from  group B, M ann-W hitney te s t p < 0.01
c. significantly d iffe rent from  group C, M ann-W hitney tes t p < 0.01
d. significantly d iffe rent from  group D, M ann-W hitney tes t p < 0.01
e. significantly d ifferent from  group E, Mann-W hitney tes t p < 0.01
f. significantly different from  group F, Mann-W hitney tes t p < 0.01
g. significantly d iffe rent from  group G, Mann-W hitney tes t p < 0.01
h. significantly d iffe rent from  group H, M ann-W hitney tes t p < 0.01
i. significantly d ifferent from  group I, Mann-W hitney tes t p < 0.01
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ant than non-fatigued cancer survivors and healthy 
persons. In the fatigued group employees with unex­
plained fatigue scored significantly lower on Pleasant 
than the other groups. CFS patients scored significantly 
lower than cancer survivors and patients with neuromus­
cular disorders.
Frightening
The scores on Frightening in the non-fatigued groups were 
similar. In the fatigued groups a dichotomy was found 
between the patients with unexplained fatigue with and 
without a chronic disease. Fatigued patients without a 
chronic disease (cancer survivors, CFS patients and 
employees) scored significantly higher on Frightening 
than fatigued patients with a chronic disease (patients 
with a neuromuscular disorder or pancreatitis).
Do perceptions o f fatigue change in patients who recover 
after treatment for fatigue?
Forty-one fatigued cancer survivors and eighty-two CFS 
patients were treated for their fatigue complaints with CBT 
at our department and filled out the FQL at pre- and post 
treatment. Sensitivity to change of the FQL was dem on­
strated by dividing the CFS patients and the cancer survi­
vors into two groups: patients who were completely 
recovered after CBT (CIS-fatigue < 35) and patients who 
remained fatigued after CBT (CIS-fatigue >= 35). Baseline 
scores on the four factors were not significantly different 
between patient who recovered and patients who 
remained fatigued. The scores on the four factors at pre- 
and post treatment were compared. Additionally, we com­
pared the post treatment scores on the four factors with 
the scores of healthy individuals (Table 5). Cancer survi­
vors who were completely recovered after CBT (n = 27) 
showed a significant decrease on the factors Frustrating, 
Exhausting and Frightening and a significant increase on 
the factor Pleasant.
The post-treatment scores were no t significantly different 
from those of healthy individuals. In contrast, the cancer 
survivors who still remained fatigued after CBT (n = 14) 
did no t show a change in the scores on the four factors 
from pre- to post treatment. Furthermore, their scores at 
post treatment were significantly different from the scores 
of healthy individuals. In investigating CFS patients who 
recovered after CBT (n = 47) the same pattern was found. 
They also decreased significantly on the factors Frustrat­
ing, Exhausting and Frightening and increased signifi­
cantly on the factor Pleasant. The scores at post treatment 
were not significantly different from those of healthy indi­
viduals. CFS patients who were not recovered after CBT (n 
= 35) showed no change between pre- and post treatment 
scores on the factors Frustrating, Exhausting and Pleasant. 
Although a significant decrease was seen on the factor 
Frightening, the post treatment scores of the four factors 
were significantly different form those of healthy individ­
uals.
Discussion
The present study shows that the FQL provides a self 
report instrument that assesses the perceptions of fatigue. 
The FQL consists of four coherent factors, namely Frustrat­
ing, Exhausting, Pleasant and Frightening. The stable pat­
tern of these factors was indicated with a confirmatory 
factor analyses, revealing an invariant internal structure in 
a second group of patients. Furthermore, the data of this
T a b le  5: C o m p a ris o n  o f  p re - and p o s t t re a tm e n t  scores on th e  fo u r  fa c to rs . C o m p a ris o n  o f  th e  p o s t t r e a tm e n t  scores w ith  th o se  o f  
h e a lth y  in d iv id u a ls
F ru s tra t in g  E x h a u s tin g  P le a sa n t F r ig h te n in g
C a n c e r s u rv iv o rs
A non fatigued after CBT (n = 27) pre-treatm ent 52.6 (27.8) 27.8 (24.4) l l . l  ( l 4.0) 22.2 (23.3)
post-treatm ent l l .9 (23.0)* 5.6 (20.0)* 36.3 (25.4)* 6.5 ( l l.2 )*
B still fatigued after CBT (n = l4 ) p re-treatm ent 67. l (27.9) 46.4 (30.8) 8.6 (l7 .0 ) l9.6 (24.4)
post-treatm ent 58.6 (34.6) 33.9 (38.7) 7.l (l2 .7 ) l2.5 ( 19.0)
C h ro n ic  F a tig u e  S y n d ro m e  P a tie n ts
C non fatigued after CBT (n = 47 pre-treatm ent 60.4 (26.5) 42.0 (3 1.8) 4.7 (8.6) 20.2 (22.5)
post-treatm ent l l . l  ( l8 . l ) * 3.2 (8.4)* 32.3 (30.5)* 5.9 ( l l.9 )*
D still fatigued after CBT (n = 35) pre-treatm ent 57.7 (30.6) 44.3 (35.9) 5.l ( l l . 2 ) 24.3 (24.6)
post-treatm ent 45.l (3 1.2) 30.0 (3 3 .l) 9 .l (l7 .0 ) 12.9 (l5 .3 )*
H e a lth y  in d iv id u a ls 7.7 ( 18.3)bd 3.9 ( l 3.4)bd 36.2 (23.3)b,d 3.2 ( l0 .2 )bd
CBT = cognitive behaviour therapy
*  significant difference between pre- and post trea tm ent scores, W ilco xon  signed rank tes t p < 0.0l
a. significantly d iffe rent from  post trea tm ent scores o f group A, M ann-W hitney-U te s t p < 0.0l
b. significantly d iffe rent from  post trea tm en t scores o f group B, M ann-W hitney-U tes t p < 0.0l
c. significantly d iffe rent from  post trea tm en t scores o f group C, Mann-W hitney-U  tes t p < 0 .0 1
d. significantly d iffe rent from  post trea tm ent scores o f group D, Mann-W hitney-U  tes t p < 0.0l
Page 5 of 7
(page number not for citation purposes)
Health and Quality o f Life Outcomes 2007, 5:36 http://www.hqlo.eom/eontent/5/1/36
study show that the FQL has adequate psychometric prop­
erties. Both the intercorrelations and the correlations of 
the four factors with the subscale CIS-fatigue were not to 
the extent that the factors could be seen as a parallel test, 
thus supporting the relative uniqueness of each factor.
The assumption that fatigue is experienced differently by 
everybody is confirmed with the data of this study. 
Severely fatigued patients had different perceptions of 
fatigue compared to healthy individuals. The healthy per­
sons described fatigue as temporary, relaxing, fulfilling, 
normal and pleasant. None of these adjectives were cho­
sen by 70% of the severely fatigued patients. Even patients 
with similar fatigue severity, appreciated fatigued differ­
ently. Different patterns were seen on the four factors of 
the FQL between the different populations of patients 
experiencing fatigue. CFS patients and severely fatigued 
employees had the highest score on the factors Frustrat­
ing, Exhausting and Frightening and also the lowest score 
on the factor Pleasant in contrast with the other fatigued 
groups. Until now the underlying aetiology of CFS still 
remains unclear [21,22]. Because the patients can not 
attribute their fatigue to a distinct cause, it's possible that 
they are more focussed on their fatigue and perceive their 
fatigue in a more negative way, than the other groups. In 
agreement with this finding, Moss-Morris et al. [23] found 
that CFS patients had a more negative view about their 
symptoms than patients with Rheumatoid arthritis (RA). 
Additionally, Taillefer et al. [24] found higher levels of ill­
ness worry in CFS patients than MS patients who were 
fatigued. Results of the FQL also showed that patients 
with a current chronic disease experience their fatigue as 
less frightening than patients with no current or a past dis­
ease. It is possible that these patients attribute their fatigue 
to their illness and therefore perceive it as less frightening. 
Cancer survivors may experience fatigue as highly anxiety 
provoking because they can see fatigue as a symptom for 
disease-recurrence. Therefore fatigue can be labelled as 
frightening [25]. Future research is necessary to examine if 
the FQL is applicable for individual assessment and fur­
thermore investigate what the effect of these different per­
ceptions is on the management of fatigue complaints in 
the clinical practice.
To reach recovery not only a decrease in fatigue severity is 
important, it is also im portant that a change in the evalu­
ation of fatigue in the patient occurs. As fatigue is also a 
part of normal health, being recovered also includes feel­
ing tired sometimes. This makes it difficult to decide 
where experiencing fatigue as a sign of illness ends and the 
experience of normal health surfaces. During CBT patients 
learn that fatigue may occur as part of normal healthy life. 
When a decrease is seen in the fatigue severity of a patient 
and the evaluation of the fatigue stays negative, it impli­
cates that a patients still suffers and is disabled due to the
fatigue. The patient cannot be seen as fully recovered [26]. 
The results of this study showed that the FQL can dem on­
strate change in fatigue perceptions following treatment 
of fatigue. Patients who were recovered after CBT had the 
same scores on all four factors compared to healthy per­
sons. So, not only the fatigue severity changed after ther­
apy but also the evaluation of fatigue. The FQL can 
therefore be a helpful tool to define full recovery in the 
clinical practice.
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Appendix A  
Fatigue quality list -  FQL
Fatigue can be described in different ways. (see table 6 for 
form)
Scoring FQL
Subsequently the four factors are calculated by summing 
the respective items (0 -  100):
Factor 1: Frustrating
T a b le  6: F a tig u e  Q u a lity  L is t
Fatigue can be described in d ifferent ways. The adjectives be low  can 
be seen as descriptions o f fatigue.
Please indicate which adjectives accurately describe the fatigue you 
experienced during the last tw o  weeks by marking them w ith  a cross. 
upsetting persistent
discouraging frustrating
tem porary relaxing
exhausting inexplicable
incessant fulfilling
wearisome insuperable
frightening unbearable
annoying normal
extrem e pleasant
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Score of each item: 20
Adjectives: discouraging, incessant, annoying, persistent, 
frustrating
Factor 2: Exhausting
Score of each item: 25
Adjectives: exhausting, wearisome, extreme, unbearable 
Factor 3: Pleasant 
Score of each item: 20
Adjectives: temporary, relaxing, fulfilling, normal, pleas­
ant
Factor 4: Frightening
Score of each item: 25
Adjectives: upsetting, frightening, inexplicable, insupera­
ble
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